ViroPharma Expects a Strong 2012 – Analyst Blog
Posted on January 06, 2012 at 16:37 PM EST
ViroPharma Inc. recently provided sales and expense guidance for 2012. The company expects net product sales in the range of $600 - $660 million.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here